Stephen Larsen
0000-0002-4867-291X
2 papers found
Refreshing results…
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia
Missing publications? Search for publications with a matching author name.